However, 64 (33%) countries still have not met the GVAP
target of [greater than or equal to] 90% national DTP3 coverage, and 71 countries (37%) have not reached the 2012-2020 Global Measles and Rubella Strategic Plan target of [greater than or equal to] 90% national MCV1 coverage (7).
Many countries worldwide have experienced large measles outbreaks in the past year, threatening efforts to achieve the GVAP target of eliminating measles in 3 WHO Regions by end-2015.
The GVAP recommends three key steps for closing the immunization gap:
In 2011, a new phase of accelerated rubella control and CRS prevention began, with updated WHO guidance for RCV introduction, Gavi funding for RCV introduction in eligible countries, and establishment of rubella elimination goals in the GVAP.
Progress toward achieving the GVAP goal of rubella elimination in five of the six WHO regions by 2020 is not on track.
To achieve measles elimination, member states should aim to fully implement measles control and elimination strategies described in GVAP
and the 2012-2020 Global Measles and Rubella Strategic Plan (10) of the Measles and Rubella Initiative, ([dagger])([dagger])([dagger]) which include achieving vaccination coverage [greater than or equal to] 95% with 2 doses of MCV administered through routine immunization or SIAs and maintaining this coverage uniformly across all districts.
outlines steps to achieve this vision and includes an accountability framework requiring annual reporting of immunization indicators to the World Health Assembly.
for the 2011-2020 Decade of Vaccines *** provides strategic objectives and recommended activities for increasing ownership, accountability, and vaccination coverage, as well as indicators for monitoring their impact through achievement of regional measles elimination targets (2).